CCG
WST icon

Cypress Capital Group’s West Pharmaceutical WST Stock Holding History

Cypress Capital Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-535
Closed -$212K – 306
2024
Q1 		$212K Buy
+535
New +$198K 0.03% 284
2023
Q4 		– Sell
-563
Closed -$211K – 305
2023
Q3 		$211K Hold
563
– – 0.03% 285
2023
Q2 		$215K Buy
+563
New +$201K 0.03% 284
2021
Q4 		– Sell
-557
Closed -$236K – 345
2021
Q3 		$236K Hold
557
– – 0.03% 254
2021
Q2 		$200K Buy
+557
New +$184K 0.03% 277

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cypress Capital Group's WST Position: Q2 2024 in Review

Cypress Capital Group sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 535 shares — an estimated $212K sold.

Cypress Capital Group first reported a position in WST in Q2 2021 and held it in 5 quarters. The position peaked at $236K in Q3 2021. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Cypress Capital Group reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Cypress Capital Group sold 535 West Pharmaceutical shares in Q2 2024, an estimated $212K.
  • Cypress Capital Group first reported a position in West Pharmaceutical in Q2 2021 and held it in 5 quarters.
  • Cypress Capital Group's West Pharmaceutical position peaked at $236K in Q3 2021.
  • 776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Cypress Capital Group's 13F filing for Q2 2024, filed 25 Jul 2024.